Computational Drug Discovery and Design

sampling: simple improvements for enhanced

mixing. J Chem Phys 135(19):194110

39. Yu T-Q, Lu J, Abrams CF et al (2016) Multi-
    scale implementation of infinite-swap replica
    exchange molecular dynamics. Proc Natl Acad
    Sci U S A 113:11744–11749


40. Wang L, Friesner RA, Berne BJ (2011) Rep-
    lica exchange with solute scaling: a more effi-
    cient version of replica exchange with solute
    tempering (REST2). J Phys Chem B
    115:9431–9438


41. Piana S, Laio A (2007) A (bias-exchange)
    approach to protein folding. J Phys Chem B
    111:4553–4559


42. Bussi G (2013) Hamiltonian replica-exchange
    in GROMACS: a flexible implementation.
    Mol Phys 112:379


43. Sabri Dashti D, Roitberg AE (2013) Optimi-
    zation of umbrella sampling replica exchange
    molecular dynamics by replica positioning. J
    Chem Theory Comput 9:4692–4699


44. Gil-Ley A, Bussi G (2015) Enhanced confor-
    mational sampling using replica exchange
    with collective-variable tempering. J Chem
    Theory Comput 11:1077–1085


45. Noe ́F, Doose S, Daidone I et al (2011) Dyna-
    mical fingerprints for probing individual
    relaxation processes in biomolecular dynamics
    with simulations and kinetic experiments.
    Proc Natl Acad Sci 108:4822–4827


46. Shukla D, Meng Y, Roux B et al (2014) Acti-
    vation pathway of Src kinase reveals interme-
    diate states as targets for drug design. Nat
    Commun 5:4397


47. Bowman GR, Ensign DL, Pande VS (2010)
    Enhanced modeling via network theory:
    adaptive sampling of Markov state models. J
    Chem Theory Comput 6:787–794


48. Doerr S, De Fabritiis G (2014) On-the-fly
    learning and sampling of ligand binding by
    high-throughput molecular simulations. J
    Chem Theory Comput 10:2064–2069


49. T. Tu, C.A. Rendleman, D.W. Borhani, et al.
    (2008) A scalable parallel framework for ana-
    lyzing terascale molecular dynamics simula-
    tion trajectories. In: 2008 SC – international
    conference for high performance computing,
    networking, storage and analysis, pp. 1–12


50. Abel R, Mondal S, Masse C et al (2017)
    Accelerating drug discovery through tight
    integration of expert molecular design and
    predictive scoring. Curr Opin Struct Biol
    43:38–44


51. B. Booth four decades of hacking biotech and
    yet biology still consumes everything.
    https://www.forbes.com/sites/brucebooth/
    2017/04/26/four-decades-of-hacking-

biotech-and-yet-biology-still-consumes-

everything/

52. Cossins BP, Lawson ADG (2015) Small mol-
    ecule targeting of protein–protein interac-
    tions through allosteric modulation of
    dynamics. Molecules 20:16435–16445


53. Shaw DE, Deneroff MM, Dror RO et al
    (2007) Anton, a special-purpose machine for
    molecular dynamics simulation. In: Proceed-
    ings of the 34th annual international sympo-
    sium on computer architecture. ACM,
    New York, NY, pp 1–12


54. Shaw DE, Grossman JP, J.A. Bank et al
    (2014) Anton 2: raising the bar for perfor-
    mance and programmability in a special-
    purpose molecular dynamics supercomputer.
    In: Proceedings of the international confer-
    ence for high performance computing, net-
    working, storage and analysis. IEEE Press,
    Piscataway, NJ, pp 41–53


55. J.P. Grossman, B. Towles, B. Greskamp, et al.
    (2015) Filtering, reductions and synchroniza-
    tion in the Anton 2 network. In: Parallel and
    distributed processing symposium (IPDPS),
    2015 I.E. international, pp. 860–870


56. Shan Y, Seeliger MA, Eastwood MP et al
    (2009) A conserved protonation-dependent
    switch controls drug binding in the Abl
    kinase. Proc Natl Acad Sci 106:139–144


57. Foda ZH, Shan Y, Kim ET et al (2015) A
    dynamically coupled allosteric network under-
    lies binding cooperativity in Src kinase. Nat
    Commun 6:5939


58. Lovera S, Sutto L, Boubeva R et al (2012)
    The different flexibility of c-Src and c-Abl
    kinases regulates the accessibility of a drug-
    gable inactive conformation. J Am Chem Soc
    134:2496–2499


59. Lin Y-L, Meng Y, Jiang W et al (2013)
    Explaining why Gleevec is a specific and
    potent inhibitor of Abl kinase. Proc Natl
    Acad Sci U S A 110:1664–1669


60. Meng Y, Lin Y, Roux B (2015) Computa-
    tional study of the “DFG-flip” conforma-
    tional transition in c-Abl and c-Src tyrosine
    kinases. J Phys Chem B 119:1443–1456


61. Morando MA, Saladino G, D’Amelio N et al
    (2016) Conformational selection and induced
    fit mechanisms in the binding of an anticancer
    drug to the c-Src kinase. Sci Rep 6:srep24439


62. Dror RO, Arlow DH, Maragakis P et al
    (2011) Activation mechanism of the β2-
    adrenergic receptor. Proc Natl Acad Sci
    108:18684–18689


63. Fan Z, Dror RO, Mildorf TJ et al (2015)
    Identifying localized changes in large systems:
    change-point detection for biomolecular

360 Benjamin P. Cossins et al.